The Framingham prediction rule is not valid in a European population of treated hypertensive patients

Abstract

The Framingham models should not be used to predict absolute CHD risk in the European population as a whole. However, these models may be used within each country, provided that cut-off points defining high-risk patients have been determined within each country.